Faculty of Medicine, Harvard School
Name will be confirmed later.
Harvard Medical School

Francois-Xavier Pellay, PhD, is a scientist and entrepreneur in the longevity industry. He is a multidisciplinary scientist with a background that includes Biochemistry, Organic Chemistry, a PhD in Bioinformatics and years of expertise as a researcher in Microbiology, Molecular Biology, Cellular Biology and Biology of Aging.
His research focused on the discovery of new longevity molecules that are now used in cosmetic products and are being explored for their use against neurodegenerative diseases.
Since 2020, he has created several companies and projects in the longevity and biotechnology industry: AFI+ (2020), a skin rejuvenation treatment based on skin cell therapy; Bimini Biotech (2020), a biotech company oriented toward the discovery of longevity solutions; Bimini Pet (2022), a cell conservation and cloning company for pets; and Longevity Retreat Yachting (2025), a B2B retreat solution for longevity clinics.
Owing to his broad expertise in longevity, he is also a consultant and member of the scientific board for diverse longevity companies, such as digital health platforms, supplement companies and longevity clinics.

General Practitioner | Longevity, Regenerative & Functional Medicine
Name will be confirmed later.
Harvard Medical School